Latent Tuberculosis
Information
- Disease name
- Latent Tuberculosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04098341 | Active, not recruiting | N/A | Screening for Tuberculosis in Pregnancy | July 3, 2019 | May 31, 2023 |
| NCT04557176 | Active, not recruiting | N/A | TB Screening Improves Preventive Therapy Uptake | November 16, 2020 | March 15, 2025 |
| NCT02712671 | Active, not recruiting | Testing for Tuberculosis in the United Kingdom HIV Infected Population | June 2013 | September 2024 | |
| NCT05412212 | Active, not recruiting | N/A | Brief Educational Video for Patients Prescribed LTBI Treatment | June 3, 2022 | February 28, 2025 |
| NCT03934931 | Active, not recruiting | N/A | Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial) | July 13, 2020 | November 8, 2024 |
| NCT03988933 | Active, not recruiting | Phase 2 | 2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB. | September 20, 2019 | December 2024 |
| NCT06408129 | Completed | COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB) | January 31, 2017 | April 9, 2024 | |
| NCT04528823 | Completed | N/A | GXT - GeneXpert or Chest-X-ray or Tuberculin Skin Testing for Household Contact Assessment | January 31, 2020 | June 30, 2023 |
| NCT01162265 | Completed | Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection | August 2010 | June 30, 2016 | |
| NCT01547884 | Completed | Effect of Filarial Infection on Immune Responses in Latent Tuberculosis | January 1, 2013 | August 7, 2020 | |
| NCT01850043 | Completed | The Epidemiology of TST Change in Korea | May 2005 | May 2012 | |
| NCT01865487 | Completed | Phase 1/Phase 2 | A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456) | August 2013 | November 2015 |
| NCT01967134 | Completed | Phase 1 | Safety and Immunogenicity Study of AERAS-456 Vaccine for Tuberculosis | November 2011 | June 2013 |
| NCT02073669 | Completed | N/A | Latent Tuberculosis in Second Generation Immigrants From High Risk Countries Compare to Low-risk Young Israeli Adults | March 2014 | November 2018 |
| NCT02090374 | Completed | N/A | Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen | March 2014 | March 2017 |
| NCT02119130 | Completed | N/A | Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa | November 1, 2014 | May 2019 |
| NCT02276755 | Completed | Phase 3 | Vitamin D Supplementation in TB Prevention | September 2015 | June 2020 |
| NCT02454738 | Completed | N/A | Ultralow Dose Computed Tomography in High-risk Drug-resistant Tuberculosis Contacts | June 2015 | June 2016 |
| NCT02690818 | Completed | N/A | Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging | April 2016 | September 26, 2018 |
| NCT03886701 | Completed | Phase 1 | Doravirine, Rifapentine and Isoniazid Interaction | April 22, 2019 | May 20, 2019 |
| NCT02880982 | Completed | Phase 3 | Trial of Vitamin D Supplementation in Cape Town Primary Schoolchildren | March 14, 2017 | June 30, 2022 |
| NCT05772065 | Completed | N/A | Clinical Practice Guidelines Versus Decision-support for Latent Tuberculosis Infection (LTBI) Management | June 1, 2023 | July 17, 2023 |
| NCT03069807 | Completed | N/A | Completion and Acceptability of Treatment Across Primary Care and the commUnity for Latent Tuberculosis | January 2017 | March 2020 |
| NCT00257907 | Completed | Immune Response to Mycobacterium Tuberculosis Infection | November 18, 2005 | February 24, 2016 | |
| NCT00763295 | Completed | Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis in Patients With HIV? | May 2008 | January 2010 | |
| NCT04830462 | Completed | Phase 4 | Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation | April 15, 2021 | May 1, 2023 |
| NCT00947609 | Completed | Improving Latent Tuberculosis (TB) Diagnosis in Thai Children | August 2009 | December 2011 | |
| NCT04331262 | Completed | Implementation of an Integrated Care Strategy for Children Contacts of Patients With Tuberculosis | July 26, 2021 | July 31, 2023 | |
| NCT06281834 | Not yet recruiting | Phase 1 | Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention | May 2024 | June 2027 |
| NCT06221735 | Not yet recruiting | N/A | Evaluating the Accuracy of New Tests for TB Infection Diagnosis | April 2024 | December 2025 |
| NCT05021731 | Not yet recruiting | Phase 4 | Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease | April 20, 2024 | April 30, 2025 |
| NCT05621343 | Recruiting | New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis | December 21, 2021 | December 2024 | |
| NCT01212003 | Recruiting | Training Protocol on the Natural History of Tuberculosis | June 30, 2011 | ||
| NCT03474029 | Recruiting | Phase 2/Phase 3 | Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI | August 1, 2019 | December 2028 |
| NCT03730181 | Recruiting | Phase 1/Phase 2 | Tuberculosis Clinical Trials Consortium Study 35 | October 12, 2019 | December 2024 |
| NCT04642755 | Recruiting | Comorbidities and Coinfections in Latent TB | April 19, 2021 | March 2026 | |
| NCT05022862 | Recruiting | N/A | Economic Incentives and vDOT for Latent Tuberculosis Infection | February 7, 2022 | October 15, 2026 |
| NCT05073926 | Recruiting | Rifampicin Resistance in S. Aureus During and After Treatment for Latent Tuberculosis | September 30, 2021 | December 2024 | |
| NCT05280886 | Recruiting | Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB) | July 24, 2018 | February 28, 2025 | |
| NCT05411744 | Recruiting | Phase 4 | One-month Latent Tuberculosis Treatment for Renal Transplant Candidates | July 1, 2022 | June 30, 2029 |
| NCT05756582 | Recruiting | Prevalence of Latent Tuberculosis Infection in Health-care Workers and Students | November 17, 2021 | December 15, 2026 | |
| NCT06022146 | Recruiting | Phase 3 | TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts | September 1, 2023 | September 1, 2026 |
| NCT01571739 | Terminated | Determining Risk in Latent Tuberculosis | January 2, 2012 | May 20, 2014 | |
| NCT04552015 | Terminated | N/A | Microneedles for Diagnosis of LTBI | April 8, 2021 | October 1, 2022 |
| NCT03010111 | Unknown status | N/A | Latent Tuberculosis Infection in Korean Health Care Workers | December 2016 | December 2017 |
| NCT02512484 | Unknown status | Improving the Detection of Active Tuberculosis in Accident and Emergency Departments | May 2016 | December 2017 | |
| NCT03220464 | Unknown status | N/A | Early Diagnosis of Active Tuberculosis Using Ultra Low-dose Chest CT | June 20, 2017 | April 30, 2020 |
| NCT03910946 | Unknown status | Prevalence of Latent Tuberculosis in High Risk Children | July 1, 2020 | February 2021 | |
| NCT00311220 | Unknown status | Phase 4 | Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers | January 2004 | November 2006 |
| NCT04188041 | Unknown status | N/A | Improving Rhode Island's Tuberculosis Preventive Services in Primary Care | October 2, 2019 | July 31, 2022 |
| NCT05541952 | Withdrawn | Phase 4 | BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population | August 17, 2020 | August 17, 2020 |
| NCT03498534 | Withdrawn | Phase 4 | Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis | September 2012 | December 2013 |
| NCT03783728 | Withdrawn | Video Based Directly Observed Therapy for Latent TB | June 30, 2019 | January 31, 2020 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D055985